CYY292 is an FGFR1 inhibitor that specifically targets the FGFR1/AKT/Snail pathway in GBM cells. CYY292 dose-dependently inhibits cancer cell proliferation, epithelial-mesenchymal transition, stemness, invasion, and migration in vitro[1].
Molecular Weight:
444.53
Purity:
99.19
CAS Number:
[2644673-04-9]
Formula:
C24H28N8O
Target:
FGFR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted